Literature DB >> 23583733

The gastrointestinal tumor microenvironment.

Michael Quante1, Julia Varga2, Timothy C Wang3, Florian R Greten4.   

Abstract

Over the past decade, the microenvironment of gastrointestinal tumors has gained increasing attention because it is required for tumor initiation, progression, and metastasis. The tumor microenvironment has many components and has been recognized as one of the major hallmarks of epithelial cancers. Although therapeutic strategies for gastrointestinal cancer have previously focused on the epithelial cell compartment, there is increasing interest in reagents that alter the microenvironment, based on reported interactions among gastrointestinal epithelial, stromal, and immune cells during gastrointestinal carcinogenesis. We review the different cellular components of the gastrointestinal tumor microenvironment and their functions in carcinogenesis and discuss how improving our understanding of the complex stromal network could lead to new therapeutic strategies.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583733      PMCID: PMC4012393          DOI: 10.1053/j.gastro.2013.03.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  162 in total

1.  Transgenic expression of VEGF in intestinal epithelium drives mesenchymal cell interactions and epithelial neoplasia.

Authors:  Amelie Boquoi; Rodrigo Jover; Tina Chen; Marieke Pennings; Greg H Enders
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

2.  Bmi1 is expressed in vivo in intestinal stem cells.

Authors:  Eugenio Sangiorgi; Mario R Capecchi
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

Review 3.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

Review 4.  Stem cells and their implications for colorectal cancer.

Authors:  Sebastian S Zeki; Trevor A Graham; Nicholas A Wright
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

5.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

6.  Cancer-related axonogenesis and neurogenesis in prostate cancer.

Authors:  Gustavo E Ayala; Hong Dai; Michael Powell; Rile Li; Yi Ding; Thomas M Wheeler; David Shine; Dov Kadmon; Timothy Thompson; Brian J Miles; Michael M Ittmann; David Rowley
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

7.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves.

Authors:  Ove Lundgren; Mats Jodal; Madeleine Jansson; Anders T Ryberg; Lennart Svensson
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

View more
  51 in total

1.  Phenotype transformation of immortalized NCM460 colon epithelial cell line by TGF-β1 is associated with chromosome instability.

Authors:  Chao Huang; Bin Wen
Journal:  Mol Biol Rep       Date:  2016-07-11       Impact factor: 2.316

Review 2.  The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis.

Authors:  Sergio Britto Garcia; Helga Stopper; Vinicius Kannen
Journal:  Cell Mol Life Sci       Date:  2014-05-22       Impact factor: 9.261

3.  Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression.

Authors:  Feng Huang; Mei Wang; Tingting Yang; Jie Cai; Qiang Zhang; Zixuan Sun; Xiaodan Wu; Xu Zhang; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-18       Impact factor: 4.553

Review 4.  Towards tumor immunodiagnostics.

Authors:  Helen Kourea; Vassiliki Kotoula
Journal:  Ann Transl Med       Date:  2016-07

5.  Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.

Authors:  Elez D Vainer; Juliane Kania-Almog; Ghadeer Zatara; Yishai Levin; Gilad W Vainer
Journal:  Mol Cell Proteomics       Date:  2020-07-08       Impact factor: 5.911

Review 6.  lnflammation-induced epigenetic switches in cancer.

Authors:  Matjaz Rokavec; Meryem Gülfem Öner; Heiko Hermeking
Journal:  Cell Mol Life Sci       Date:  2015-09-22       Impact factor: 9.261

7.  Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.

Authors:  Nicholas Osborne; Rebecca Sundseth; Julian Burks; Hong Cao; Xunxian Liu; Alexander H Kroemer; Lynda Sutton; Allen Cato; Jill P Smith
Journal:  Cancer Immunol Immunother       Date:  2019-09-24       Impact factor: 6.968

Review 8.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

Review 9.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.

Authors:  L-F Wang; Y-S Liu; B Yang; P Li; X-S Cheng; C-X Xiao; J-J Liu; S Li; J-L Ren; B Guleng
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.